Published in Pediatr Nephrol on May 22, 2013
Rituximab fails where eculizumab restores renal function in C3nef-related DDD. Pediatr Nephrol (2014) 1.03
Biologics for the treatment of autoimmune renal diseases. Nat Rev Nephrol (2016) 0.97
Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach. J Am Soc Nephrol (2015) 0.96
Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. J Am Soc Nephrol (2013) 0.95
Update on C3 glomerulopathy. Nephrol Dial Transplant (2014) 0.94
Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy. Immunobiology (2015) 0.90
Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis. Clin Kidney J (2015) 0.87
Eculizumab in dense-deposit disease after renal transplantation. Pediatr Nephrol (2014) 0.87
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis. Kidney Int (2015) 0.84
Eculizumab in Pediatric Dense Deposit Disease. Clin J Am Soc Nephrol (2015) 0.84
A case of C3 glomerulonephritis successfully treated with eculizumab. Pediatr Nephrol (2015) 0.82
Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy. J Am Soc Nephrol (2015) 0.80
Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol (2015) 0.80
Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy. Diagn Pathol (2016) 0.76
C3 Glomerulopathy. Pediatr Nephrol (2016) 0.76
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN. World J Nephrol (2016) 0.76
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience. Diagn Pathol (2015) 0.75
C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy. Kidney Int (2017) 0.75
American Society of Nephrology clinical pathological conference. Clin J Am Soc Nephrol (2014) 0.75
Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study. Kidney Res Clin Pract (2014) 0.75
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders. Clin Exp Immunol (2016) 0.75
Complement related kidney diseases: Recurrence after transplantation. World J Transplant (2016) 0.75
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea. Clin Kidney J (2017) 0.75
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet (2010) 3.74
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet (2006) 3.24
C3 glomerulopathy: a new classification. Nat Rev Nephrol (2010) 3.17
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet (2005) 2.92
Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol (2012) 2.83
Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int (2011) 2.61
Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat (2010) 2.44
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest (2010) 2.18
Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol (2008) 2.08
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol (2011) 1.92
Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up. Pediatr Allergy Immunol (2001) 1.80
Eculizumab for the treatment of dense-deposit disease. N Engl J Med (2012) 1.76
Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol (2012) 1.70
Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med (1983) 1.70
Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet (2009) 1.67
Eculizumab in a patient with dense-deposit disease. N Engl J Med (2012) 1.67
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haematologica (2007) 1.62
C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int (2008) 1.61
Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies. Am J Transplant (2012) 1.40
Dense deposit disease. Mol Immunol (2011) 1.31
Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol (2011) 1.29
New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab. Semin Thromb Hemost (2010) 1.24
Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN) Clin Immunol Immunopathol (1978) 1.05
Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane. Clin Nephrol (1977) 1.04
Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis. Clin Nephrol (1982) 1.04
Low-dose rituximab in adult patients with primary immune thrombocytopenia. Eur J Haematol (2010) 0.96
Idiopathic membranoproliferative glomerulonephritis. Morphology and natural history. Perspect Nephrol Hypertens (1973) 0.80
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int (2012) 3.05
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol (2012) 2.83
Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. J Am Chem Soc (2007) 2.01
Novel plasmid and its variant harboring both a bla(NDM-1) gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii. Antimicrob Agents Chemother (2012) 1.97
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol (2011) 1.92
Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int (2012) 1.81
Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years. Transplantation (2006) 1.81
Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int (2005) 1.70
Pulmonary tumor thrombotic microangiopathy with cor pulmonale due to desmoplastic small round cell tumor. J Pediatr (2012) 1.70
Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis (2004) 1.59
HTQC: a fast quality control toolkit for Illumina sequencing data. BMC Bioinformatics (2013) 1.58
Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am J Kidney Dis (2010) 1.57
Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4). Proc Natl Acad Sci U S A (2011) 1.48
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res (2010) 1.42
Reducing the exome search space for mendelian diseases using genetic linkage analysis of exome genotypes. Genome Biol (2011) 1.38
Allelic variants of complement genes associated with dense deposit disease. J Am Soc Nephrol (2011) 1.38
QDMR: a quantitative method for identification of differentially methylated regions by entropy. Nucleic Acids Res (2011) 1.37
Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol (2013) 1.37
A claudin-9-based ion permeability barrier is essential for hearing. PLoS Genet (2009) 1.29
Inactivation of NADPH oxidase organizer 1 results in severe imbalance. Curr Biol (2006) 1.27
C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis (2013) 1.24
DiseaseMeth: a human disease methylation database. Nucleic Acids Res (2011) 1.22
Human male infertility caused by mutations in the CATSPER1 channel protein. Am J Hum Genet (2009) 1.19
Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood (2013) 1.19
The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer. Clin Cancer Res (2011) 1.19
Clinical resolution of glycogenic hepatopathy following improved glycemic control. J Diabetes Complications (2008) 1.18
A mechanism for synergy with combined mTOR and PI3 kinase inhibitors. PLoS One (2011) 1.12
Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed (2013) 1.11
Biomimetic approach to perophoramidine and communesin via an intramolecular cyclopropanation reaction. Org Lett (2006) 1.09
Recurrent respiratory papillomatosis: pathogenesis to treatment. Curr Opin Otolaryngol Head Neck Surg (2005) 1.07
Treatment options for C3 glomerulopathy. Curr Opin Nephrol Hypertens (2013) 1.07
Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels. J Cell Mol Med (2009) 1.07
Integrating qualitative and quantitative characterization of traditional Chinese medicine injection by high-performance liquid chromatography with diode array detection and tandem mass spectrometry. J Sep Sci (2014) 1.06
Selective cochlear degeneration in mice lacking the F-box protein, Fbx2, a glycoprotein-specific ubiquitin ligase subunit. J Neurosci (2007) 1.06
MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol (2010) 1.04
Genetic male infertility and mutation of CATSPER ion channels. Eur J Hum Genet (2010) 1.03
Promoter, alternative splice forms, and genomic structure of protocadherin 15. Genomics (2007) 0.98
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer (2010) 0.97
CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. Cancer Lett (2011) 0.96
A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome. Nephrol Dial Transplant (2010) 0.95
Abyssomicins from the South China Sea deep-sea sediment Verrucosispora sp.: natural thioether Michael addition adducts as antitubercular prodrugs. Angew Chem Int Ed Engl (2012) 0.95
Total synthesis of (+)-perophoramidine and determination of the absolute configuration. J Am Chem Soc (2010) 0.93
Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation (2005) 0.92
Dense deposit disease and the factor H H402 allele. Clin Exp Nephrol (2008) 0.92
Simultaneous quantification of niacin and its three main metabolites in human plasma by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.92
Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3. Am J Kidney Dis (2012) 0.91
Determination of crystallographic orientation of large grain metals with surface acoustic waves. J Acoust Soc Am (2012) 0.91
A comparison of melancholic and nonmelancholic recurrent major depression in Han Chinese women. Depress Anxiety (2011) 0.90
Cholesterol granuloma of the maxillary sinus. Arch Pathol Lab Med (2002) 0.90
Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant (2005) 0.89
Synthesis and absolute configuration of hormone alpha1. Nat Chem Biol (2008) 0.89
Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest (2016) 0.88
Right ventricular hemangioma causing right ventricular inflow obstruction and right heart failure. J Am Soc Echocardiogr (2004) 0.88
A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome. Pediatr Nephrol (2013) 0.87
Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies. Clin Transplant (2005) 0.87
CFTR-deficient pigs display peripheral nervous system defects at birth. Proc Natl Acad Sci U S A (2013) 0.87
Epigenetic modification restores functional PR expression in endometrial cancer cells. Curr Pharm Des (2014) 0.86
Expression of p14(ARF), p15(INK4b), p16(INK4a) and skp2 increases during esophageal squamous cell cancer progression. Exp Ther Med (2012) 0.85
Mechanism of BDE209-induced impaired glucose homeostasis based on gene microarray analysis of adult rat liver. Arch Toxicol (2013) 0.83
Microdeletion of 17q22q23.2 encompassing TBX2 and TBX4 in a patient with congenital microcephaly, thyroid duct cyst, sensorineural hearing loss, and pulmonary hypertension. Am J Med Genet A (2011) 0.83
Australian marine sponge alkaloids as a new class of glycine-gated chloride channel receptor modulator. Bioorg Med Chem (2013) 0.83
Sesterterpene glycinyl-lactams: a new class of glycine receptor modulator from Australian marine sponges of the genus Psammocinia. Org Biomol Chem (2013) 0.83
Successful transplantation of kidneys from deceased donors with acute renal failure: Three-year results. Transplantation (2006) 0.82
Diagnosis and treatment of C3 glomerulopathy. Clin Nephrol (2013) 0.82
A novel initialization method for nonnegative matrix factorization and its application in component recognition with three-dimensional fluorescence spectra. Spectrochim Acta A Mol Biomol Spectrosc (2011) 0.82
Spiralisones A-D: acylphloroglucinol hemiketals from an Australian marine brown alga, Zonaria spiralis. Org Biomol Chem (2012) 0.81
Thymolipoma: clues to pathogenesis revealed by cytogenetics. Ann Diagn Pathol (2008) 0.81
Fluorescence microscopy is superior to polarized microscopy for detecting amyloid deposits in Congo red-stained trephine bone marrow biopsy specimens. Am J Clin Pathol (2012) 0.81
Characterization of human αβTCR repertoire and discovery of D-D fusion in TCRβ chains. Protein Cell (2014) 0.81
Genome-wide copy number variation analysis of a Branchio-oto-renal syndrome cohort identifies a recombination hotspot and implicates new candidate genes. Hum Genet (2013) 0.81
Sialoendoscopy for the treatment of pediatric salivary gland disorders. Arch Otolaryngol Head Neck Surg (2012) 0.80
Whipple pancarditis as a cause of heart failure. Ann Intern Med (2004) 0.80
[Distribution and normal reference range of fetal nuchal translucency thickness in Kunming pregnant women in the first trimester]. Zhonghua Fu Chan Ke Za Zhi (2012) 0.79
Rare Streptomyces sp. polyketides as modulators of K-Ras localisation. Org Biomol Chem (2014) 0.79
Identification of potential biomarkers for predicting acute dermal irritation by proteomic analysis. J Appl Toxicol (2011) 0.79
[Treatment of congenital hypertrophic pyloric stenosis with endoscopic pyloromyotomy]. Zhonghua Er Ke Za Zhi (2008) 0.79
Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. Clin Transplant (2003) 0.79
Callyspongisines A-D: bromopyrrole alkaloids from an Australian marine sponge, Callyspongia sp. Org Biomol Chem (2014) 0.78
Diurnal variations in hypnotic responsiveness: is there an optimal time to be hypnotized? Int J Clin Exp Hypn (2015) 0.78
Streptococcal infection as possible trigger for dense deposit disease (C3 glomerulopathy). Eur J Pediatr (2014) 0.78
Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies. J Immunol (2013) 0.78
Heavy metals chromium and neodymium reduced phosphorylation level of heat shock protein 27 in human keratinocytes. Toxicol In Vitro (2010) 0.78
Pharmacokinetics of lansoprazole and its main metabolites after single intravenous doses in healthy Chinese subjects. Xenobiotica (2012) 0.77
[Studies on extraction process of Fructus Schisandrae chinensis and Fructus Ligustri lucidi in gandening tablet]. Zhongguo Zhong Yao Za Zhi (2004) 0.77
Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma. Head Neck (2011) 0.77
Relationship between leg length and gestational diabetes mellitus in Chinese pregnant women. Diabetes Care (2007) 0.77
Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells. Arch Toxicol (2013) 0.76
Expression of curcin-transferrin receptor binding peptide fusion protein and its anti-tumor activity. Protein Expr Purif (2013) 0.76
Headbobber: a combined morphogenetic and cochleosaccular mouse model to study 10qter deletions in human deafness. PLoS One (2013) 0.76
Thin-film optoacoustic transducers for subcellular Brillouin oscillation imaging of individual biological cells. Appl Opt (2015) 0.76
Pilot study of mycophenolate mofetil for treatment of kidney disease due to congenital urinary tract disorders in children. Am J Kidney Dis (2008) 0.75
[Research on night visibility estimation method based on image features of dual light sources]. Guang Pu Xue Yu Guang Pu Fen Xi (2014) 0.75
[Study on a new method of fast monitoring toxicity of Cd2+ by algal in water]. Huan Jing Ke Xue (2014) 0.75
[Analysis of three-dimensional fluorescence overlapping spectra using differential spectra and independent component analysis]. Guang Pu Xue Yu Guang Pu Fen Xi (2013) 0.75
Hydrothermal synthetic mercaptopropionic acid stabled CdTe quantum dots as fluorescent probes for detection of Ag⁺. Spectrochim Acta A Mol Biomol Spectrosc (2012) 0.75
Peripheral blood transcriptome sequencing reveals rejection-relevant genes in long-term heart transplantation. Int J Cardiol (2013) 0.75